Active Biotech AB (publ) filed its Annual on Apr 26, 2023 for the period ending Dec 31, 2022. In this report its auditor, KPMG LLP - Klynveld Peat Marwick Goerdeler, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.507 SEK | -1.93% | -0.59% | +11.06% |
03:53pm | Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug | MT |
May. 08 | Active Biotech AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.06% | 17.48M | |
+10.11% | 114B | |
+12.79% | 107B | |
-5.63% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-6.52% | 17.51B | |
-39.36% | 17.17B | |
+6.88% | 14.14B | |
+35.25% | 12.2B |
- Stock Market
- Equities
- ACTI Stock
- News Active Biotech AB
- Active Biotech AB Auditor Raises 'Going Concern' Doubt